These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33957693)

  • 21. Monitoring of serum HBV RNA, HBcrAg, HBsAg and anti-HBc levels in patients during long-term nucleoside/nucleotide analogue therapy.
    Liao H; Liu Y; Li X; Wang J; Chen X; Zou J; Li Q; Liu L; Wang J; Huang B; Lu F; Xu D
    Antivir Ther; 2019; 24(2):105-115. PubMed ID: 30511941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between hepatitis B core-related antigen levels and sustained HBeAg seroconversion in patients treated with nucleo(s)tide analogues.
    Sonneveld MJ; van Oord GW; van Campenhout MJ; De Man RA; Janssen HLA; de Knegt RJ; Boonstra A; van der Eijk AA
    J Viral Hepat; 2019 Jul; 26(7):828-834. PubMed ID: 30896057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel biomarkers for the management of chronic hepatitis B.
    Inoue T; Tanaka Y
    Clin Mol Hepatol; 2020 Jul; 26(3):261-279. PubMed ID: 32536045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between HBcrAg and HBV reinfection in HBV related post-liver transplantation patients.
    Urabe A; Imamura M; Tsuge M; Kan H; Fujino H; Fukuhara T; Masaki K; Kobayashi T; Ono A; Nakahara T; Kawaoka T; Hiramatsu A; Kawakami Y; Aikata H; Hayes CN; Maki N; Ohdan H; Chayama K
    J Gastroenterol; 2017 Mar; 52(3):366-375. PubMed ID: 27422771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients.
    Cheng HR; Yang HC; Lin SR; Yang TY; Lin YY; Su TH; Tseng TC; Liu CJ; Kao JH
    Hepatol Int; 2021 Jun; 15(3):582-592. PubMed ID: 33886088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum HBcrAg and Hepatocellular Carcinoma in a Taiwanese Population Seronegative for HBsAg and Anti-HCV.
    Hsieh YC; Pan MH; Jeng WJ; Hu HH; Liu J; Mizokami M; Chen CJ; Yang HI
    Clin Gastroenterol Hepatol; 2023 May; 21(5):1303-1313.e11. PubMed ID: 35850414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between serum hepatitis B virus core-related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients.
    Suzuki F; Miyakoshi H; Kobayashi M; Kumada H
    J Med Virol; 2009 Jan; 81(1):27-33. PubMed ID: 19031469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.
    Tseng TC; Liu CJ; Hsu CY; Hong CM; Su TH; Yang WT; Chen CL; Yang HC; Huang YT; Fang-Tzu Kuo S; Liu CH; Chen PJ; Chen DS; Kao JH
    Gastroenterology; 2019 Dec; 157(6):1518-1529.e3. PubMed ID: 31470004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of Hepatitis B Core-Related Antigen Versus Hepatitis B Surface Antigen and Hepatitis B Virus DNA in Predicting HBeAg-positive and HBeAg-negative Chronic Hepatitis.
    Zhang ZQ; Wang YB; Lu W; Liu DP; Shi BS; Zhang XN; Huang D; Li XF; Zhou XL; Ding RR
    Ann Lab Med; 2019 Jan; 39(1):67-75. PubMed ID: 30215232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D.
    Maasoumy B; Wiegand SB; Jaroszewicz J; Bremer B; Lehmann P; Deterding K; Taranta A; Manns MP; Wedemeyer H; Glebe D; Cornberg M
    Clin Microbiol Infect; 2015 Jun; 21(6):606.e1-10. PubMed ID: 25700889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum hepatitis B core-related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis B.
    Chen EQ; Feng S; Wang ML; Liang LB; Zhou LY; Du LY; Yan LB; Tao CM; Tang H
    Sci Rep; 2017 Mar; 7(1):173. PubMed ID: 28282964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combining Hepatitis B Virus RNA and Hepatitis B Core-Related Antigen: Guidance for Safely Stopping Nucleos(t)ide Analogues in Hepatitis B e Antigen-Positive Patients With Chronic Hepatitis B.
    Fan R; Peng J; Xie Q; Tan D; Xu M; Niu J; Wang H; Ren H; Chen X; Wang M; Sheng J; Tang H; Bai X; Wu Y; Zhou B; Sun J; Hou J;
    J Infect Dis; 2020 Jul; 222(4):611-618. PubMed ID: 32211776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combining end-of-treatment HBsAg and baseline hepatitis B core-related antigen reduce HBV relapse rate after tenofovir cessation.
    Kuo YH; Wang JH; Hung CH; Lu SN; Hu TH; Chen CH
    Hepatol Int; 2021 Apr; 15(2):301-309. PubMed ID: 33665773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First-line oral antiviral therapies showed similar efficacies in suppression of serum HBcrAg in chronic hepatitis B patients.
    Mak LY; Wong DK; Cheung KS; Seto WK; Fung J; Yuen MF
    BMC Gastroenterol; 2021 Mar; 21(1):123. PubMed ID: 33731023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review article: novel biomarkers in hepatitis B infection.
    Lok J; Dusheiko G; Carey I; Agarwal K
    Aliment Pharmacol Ther; 2022 Sep; 56(5):760-776. PubMed ID: 35770458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum HBcrAg is better than HBV RNA and HBsAg in reflecting intrahepatic covalently closed circular DNA.
    Chen EQ; Wang ML; Tao YC; Wu DB; Liao J; He M; Tang H
    J Viral Hepat; 2019 May; 26(5):586-595. PubMed ID: 30632235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy.
    Matsumoto A; Nishiguchi S; Enomoto H; Kang JH; Tanaka Y; Shinkai N; Kurosaki M; Enomoto M; Kanda T; Yokosuka O; Yatsuhashi H; Nagaoka S; Okuse C; Kagawa T; Mine T; Takaguchi K; Saito S; Hino K; Ikeda F; Sakisaka S; Morihara D; Miyase S; Tsuge M; Chayama K; Hiramatsu N; Suzuki Y; Murata K; Tanaka E
    J Gastroenterol; 2018 Feb; 53(2):247-257. PubMed ID: 28634723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B virus core-related antigens as markers for monitoring chronic hepatitis B infection.
    Wong DK; Tanaka Y; Lai CL; Mizokami M; Fung J; Yuen MF
    J Clin Microbiol; 2007 Dec; 45(12):3942-7. PubMed ID: 17942661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New Biomarkers of Chronic Hepatitis B.
    Mak LY; Seto WK; Fung J; Yuen MF
    Gut Liver; 2019 Nov; 13(6):589-595. PubMed ID: 30919601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of different viral biomarkers on the management of chronic hepatitis B.
    Mak LY; Hui RW; Fung J; Seto WK; Yuen MF
    Clin Mol Hepatol; 2023 Apr; 29(2):263-276. PubMed ID: 36655304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.